Belgium vs Kazakhstan: Laboratories providing drug susceptibility testing (DST)
Belgium
6.2
in 2014
Kazakhstan
6.3
in 2014
Belgium rank
18th
Kazakhstan rank
17th
Laboratories providing drug susceptibility testing (DST) over time
- Belgium
- Kazakhstan
How they compare
Kazakhstan currently reports 6.3 against 6.2 in Belgium, a difference of 0.1.
The two have swapped places 3 times across 8 shared years of data; in 2006 it was Belgium ahead.
Belgium ranks 18th and Kazakhstan ranks 17th of 157 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Belgium | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.93 | 6.23 | 1.7 | Belgium |
| 2010s | 6.4 | 6.5 | 0.1 | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), Belgium or Kazakhstan?
- Kazakhstan, at 6.3 against 6.2 in Belgium as of 2014.
- What is the difference in laboratories providing drug susceptibility testing (dst) between Belgium and Kazakhstan?
- 0.1, with Kazakhstan ahead.
- How many years of comparable data are there for Belgium and Kazakhstan?
- 8 years are reported by both, from 2006 to 2014.
- How do Belgium and Kazakhstan rank globally for laboratories providing drug susceptibility testing (dst)?
- Belgium ranks 18th and Kazakhstan ranks 17th of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.